These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 34663439)
1. Optimization of sepsis therapy based on patient-specific digital precision diagnostics using next generation sequencing (DigiSep-Trial)-study protocol for a randomized, controlled, interventional, open-label, multicenter trial. Brenner T; Skarabis A; Stevens P; Axnick J; Haug P; Grumaz S; Bruckner T; Luntz S; Witzke O; Pletz MW; Ruprecht TM; Marschall U; Altin S; Greiner W; Berger MM; Trials; 2021 Oct; 22(1):714. PubMed ID: 34663439 [TBL] [Abstract][Full Text] [Related]
2. Next-generation sequencing diagnostics of bacteremia in sepsis (Next GeneSiS-Trial): Study protocol of a prospective, observational, noninterventional, multicenter, clinical trial. Brenner T; Decker SO; Grumaz S; Stevens P; Bruckner T; Schmoch T; Pletz MW; Bracht H; Hofer S; Marx G; Weigand MA; Sohn K; Medicine (Baltimore); 2018 Feb; 97(6):e9868. PubMed ID: 29419698 [TBL] [Abstract][Full Text] [Related]
3. Next-generation sequencing diagnostics of bacteremia in pediatric sepsis. Schmoch T; Westhoff JH; Decker SO; Skarabis A; Hoffmann GF; Dohna-Schwake C; Felderhoff-Müser U; Skolik C; Feisst M; Klose C; Bruckner T; Luntz S; Weigand MA; Sohn K; Brenner T Medicine (Baltimore); 2021 Jun; 100(25):e26403. PubMed ID: 34160425 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of droplet digital PCR rapid detection method and precise diagnosis and treatment for suspected sepsis (PROGRESS): a study protocol for a multi-center pragmatic randomized controlled trial. Zhao Y; Lin K; Zhang H; Yuan G; Zhang Y; Pan J; Hong L; Huang Y; Ye Y; Huang L; Chen X; Liu J; Li X; He X; Yue Q; Zhang H; Zhou A; Zhuang Y; Chen J; Wu C; Zhou W; Cai F; Zhang S; Li L; Li S; Bian T; Li J; Yin J; Ruan Z; Xu S; Zhang Y; Chen J; Zhang Y; Han J; Su T; Tu F; Jiang L; Lei C; Du Q; Ai J; Zhang W BMC Infect Dis; 2022 Jul; 22(1):630. PubMed ID: 35854212 [TBL] [Abstract][Full Text] [Related]
5. EXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock-a study protocol for a randomized, prospective, multicenter, open-label, controlled, parallel-group trial. David S; Bode C; Stahl K; Trials; 2023 Apr; 24(1):277. PubMed ID: 37061693 [TBL] [Abstract][Full Text] [Related]
6. Enhanced Performance of Next-Generation Sequencing Diagnostics Compared With Standard of Care Microbiological Diagnostics in Patients Suffering From Septic Shock. Grumaz S; Grumaz C; Vainshtein Y; Stevens P; Glanz K; Decker SO; Hofer S; Weigand MA; Brenner T; Sohn K Crit Care Med; 2019 May; 47(5):e394-e402. PubMed ID: 30720537 [TBL] [Abstract][Full Text] [Related]
7. Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock - rationale and design of a multicenter randomized controlled superiority trial. Roggeveen LF; Fleuren LM; Guo T; Thoral P; de Grooth HJ; Swart EL; Klausch TLT; van der Voort PHJ; Girbes ARJ; Bosman RJ; Elbers PWG Trials; 2019 Dec; 20(1):745. PubMed ID: 31852491 [TBL] [Abstract][Full Text] [Related]
9. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se). Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416 [TBL] [Abstract][Full Text] [Related]
10. Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial. Unger M; Morelli A; Singer M; Radermacher P; Rehberg S; Trimmel H; Joannidis M; Heinz G; Cerny V; Dostál P; Siebers C; Guarracino F; Pratesi F; Biancofiore G; Girardis M; Kadlecova P; Bouvet O; Zörer M; Grohmann-Izay B; Krejcy K; Klade C; Krumpl G Trials; 2018 Nov; 19(1):637. PubMed ID: 30454042 [TBL] [Abstract][Full Text] [Related]
11. Optimising Treatment Outcomes for Children and Adults Through Rapid Genome Sequencing of Sepsis Pathogens. A Study Protocol for a Prospective, Multi-Centre Trial (DIRECT). Irwin AD; Coin LJM; Harris PNA; Cotta MO; Bauer MJ; Buckley C; Balch R; Kruger P; Meyer J; Shekar K; Brady K; Fourie C; Sharp N; Vlad L; Whiley D; Beatson SA; Forde BM; Paterson D; Clark J; Hajkowicz K; Raman S; Bialasiewicz S; Lipman J; Schlapbach LJ; Roberts JA Front Cell Infect Microbiol; 2021; 11():667680. PubMed ID: 34249774 [TBL] [Abstract][Full Text] [Related]
12. Next-generation sequencing diagnostics of bacteremia in septic patients. Grumaz S; Stevens P; Grumaz C; Decker SO; Weigand MA; Hofer S; Brenner T; von Haeseler A; Sohn K Genome Med; 2016 Jul; 8(1):73. PubMed ID: 27368373 [TBL] [Abstract][Full Text] [Related]
13. Remote ischemic conditioning in septic shock (RECO-Sepsis): study protocol for a randomized controlled trial. Cour M; Buisson M; Klouche K; Bouzgarrou R; Schwebel C; Quenot JP; Zeni F; Beuret P; Ovize M; Argaud L Trials; 2019 May; 20(1):281. PubMed ID: 31118101 [TBL] [Abstract][Full Text] [Related]
14. Sepsis Care Pathway 2019. Labib A Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206 [No Abstract] [Full Text] [Related]
15. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Soares MO; Welton NJ; Harrison DA; Peura P; Shankar- Hari M; Harvey SE; Madan JJ; Ades AE; Palmer SJ; Rowan KM Health Technol Assess; 2012; 16(7):1-186. PubMed ID: 22361003 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial. Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW; Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029 [TBL] [Abstract][Full Text] [Related]
19. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis. Prkno A; Wacker C; Brunkhorst FM; Schlattmann P Crit Care; 2013 Dec; 17(6):R291. PubMed ID: 24330744 [TBL] [Abstract][Full Text] [Related]
20. Microbial cell-free DNA-sequencing as an addition to conventional diagnostics in neonatal sepsis. Balks J; Grumaz S; Mazzitelli S; Neder U; Lemloh L; Melaku T; Glaser K; Mueller A; Kipfmueller F Pediatr Res; 2024 Aug; ():. PubMed ID: 39143203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]